Latest news

LynxCare ranked in the CB Insights’ 2022 ‘Digital Health 150' list

Talk to an Expert

Leuven, Belgium, December 8, 2022 – CB Insights has released its “Digital Health 150” 2022 list, ranking LynxCare among the 150 most promising digital health startups in the world.  With only 8% European digital health startups in the ranks, LynxCare is honored to be among the 3 Belgian companies taking the lead in the Belgian and European health tech startup space.

LynxCare was selected from a pool of over 13,000 companies, including applicants and nominees. Based on various factors including, but not limited to, company business models and momentum in the market, funding, investor profiles, competitive positioning, tech novelty; CB insights selected 150 top private companies transforming healthcare with digital technology. The winning companies include startups working on among others interoperability and data integration, home care and monitoring, AR/VR in healthcare, and hybrid care. 

Our ranking in this year’s Digital Health 150 List is a great recognition for the LynxCare team and the contributions we have made together with our partners to further improve patient care and scientific research in the EU and beyond. 2022 was a year of many milestones for the company: our €20M Series A investment round, the partnership with PSIH to accelerate our expansion in France and the significant team growth, to name a few.

Being named among the 18 most promising digital health tech companies active in Interoperability, Data & Analytics, is a testament to LynxCare’s data infrastructure and governance. LynxCare's core is to build AI/NLP systems that meet "human-like" accuracy without compromising on scalability. Our granular, research- and regulatory-gradedatabases are set up according to OMOP Common Data Model standards, ensuring the data is FAIR (Findable, Accessible, Interoperable and Reusable). This allows LynxCare to help hospitals make Real World Data accessible for research with the ultimate goal to improve patient outcomes across the globe.

About CB Insights

CB Insights builds software that enables the world’s best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. 

Learn more:

About LynxCare 

LynxCare is the Belgian-US scale-up leading Big Data in healthcare. With an AI-driven data platform, they enable hospitals to unlock previously unavailable insights for better patient care and scientific research. Founded in 2015 by Georges De Feu (pharmacist) and Dries Hens (physician), LynxCare today is a rapidly growing Belgian scale-up backed by a 20Mio EUR Series A from venture capitalist funds like MTIP (CH), Elaia (FR), BtoV (DE) and Heran partners (BE). LynxCare currently employs more than 50 people, including doctors, biomedical scientists, data specialists of which 15+ researchers (PhD). They work with leading hospitals in Europe and the United States and facilitate scientific research for life sciences companies such as AstraZeneca, Pfizer, Johnson & Johnson and Novartis within a strict ethical and legal framework.

Learn more:

CB Insights has released its “Digital Health 150” 2022 list, ranking LynxCare among the 150 most promising digital health startups in the world.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.